These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13799542)

  • 21. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory virus vaccines. 3. Some biological properties of Sephadex-purified ether-extracted influenza virus antigens.
    Brandon FB; Cox F; Lease GO; Timm EA; Quinn E; McLean IW
    J Immunol; 1967 Apr; 98(4):800-5. PubMed ID: 5336967
    [No Abstract]   [Full Text] [Related]  

  • 24. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
    O'Hagan DT
    Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Innate recognition of influenza virus and vaccine development].
    Ichinohe T
    Uirusu; 2015; 65(1):127-34. PubMed ID: 26923967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On vaccinal strains of influenza viruses].
    RITOVA VV; EVSTIGNEEVA NA
    Vopr Virusol; 1960; 5():172-8. PubMed ID: 14437613
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on influenza virus. IV. Studies on the influenza virus vaccine immunization experiment of man with influenza virus vaccine inactivated with sodium ethylmercurithiosalicylate.
    NAGAKI D; HAGA T; IWASAKI K; NAKASE Y; UCHIYAMA T
    Kitasato Arch Exp Med; 1954 Jun; 27(1-2):1-7. PubMed ID: 13296317
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of Streptococcus pneumoniae and influenza virus vaccines in the chinchilla otitis media model.
    Giebink GS
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S42-4. PubMed ID: 2648295
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influenza virus and other viruses. 15 years' study and research - 1944-1959. I. Isolation of the virus - anti-influenza preventive vaccine].
    LACORTE JG; MONTEIRO E; LOURES JC
    Rev Bras Med; 1960 Mar; 17():246-50 contd. PubMed ID: 13758102
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on influenza virus. III. Studies on the influenza virus vaccine; immunization experiment of mice with the influenza virus vaccine inactivated by sodium ethylmercurithiosalicylate.
    NAGAKI D; IWASAKI K; HOMMA S; NAKASE Y; UCHIYAMA T
    Kitasato Arch Exp Med; 1953 Dec; 26(4):209-15. PubMed ID: 13286892
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
    Lai CH; Tang N; Jan JT; Huang MH; Lu CY; Chiang BL; Huang LM; Wu SC
    Vaccine; 2015 Aug; 33(35):4321-9. PubMed ID: 25858857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward a universal influenza virus vaccine: prospects and challenges.
    Pica N; Palese P
    Annu Rev Med; 2013; 64():189-202. PubMed ID: 23327522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research progress and prospect of universal influenza vaccine].
    Luo DY; Xue CY; Cao YC
    Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommended composition of influenza virus vaccines for use in the 2002 influenza season.
    Wkly Epidemiol Rec; 2001 Oct; 76(40):311-4. PubMed ID: 11676104
    [No Abstract]   [Full Text] [Related]  

  • 37. The future of cell culture-based influenza vaccine production.
    Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
    Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
    Liu Q; Xue C; Zheng J; Liu K; Wang Y; Wei Y; Liu GD; Cao Y
    Vaccine; 2015 Jul; 33(32):4035-40. PubMed ID: 26100927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New criteria for the selection of influenza vaccine strains.
    Fazekas de St Groth
    Bull World Health Organ; 1969; 41(3):651-7. PubMed ID: 5309491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza viruses: an introduction.
    Kawaoka Y; Neumann G
    Methods Mol Biol; 2012; 865():1-9. PubMed ID: 22528150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.